Phase 1: Enactment & build · Step 1.10
Create the Health Technology Assessment Institute
Months 0–18; continuous · HTA Institute (independent, within HHS)Discuss this step
Every concrete action this step requires, who is responsible, and when it happens relative to enactment.
| # | Action | Owner | When | Trade-off |
|---|---|---|---|---|
| 1.10.1 | Merge PCORI and AHRQ's evidence centers into the Institute; staff about 600 analysts and clinicians. | HHS | Month 0–12 | Merging PCORI and AHRQ builds a capable institute quickly but may shift their missions from research to coverage decisions. |
| 1.10.2 | Publish methods: comparative effectiveness and budget impact. If cost-per-QALY is used, also report results without it, to address disability-discrimination concerns. | HTA Institute | Month 6 | Reporting results with and without QALYs addresses disability-rights concerns but complicates decisions. |
| 1.10.3 | Build a 'low-value care' list (e.g., imaging for uncomplicated low-back pain, vitamin D screening) for non-coverage or clinical guidance. | HTA Institute | Year 1–2 | A low-value care list reduces waste but restricts some services patients and physicians want. |
| 1.10.4 | Set a 180-day maximum for assessment of new drugs and devices, with provisional coverage during review. | HTA Institute | Month 12 | Provisional coverage during review speeds access but makes later removal politically hard. |